Page 30 - FoodFocusThailand No.243 July 2026
P. 30

SPECIAL FOCUS FOCUS
            SPECIAL


























            FERMENTED SOYBEAN AS A HEALTH

            FUNCTIONAL ENHANCER:


            FROM TRADITIONAL WISDOM TO


            FUTURE FUNCTIONAL INGREDIENTS



            Over the past decade, the global food industry has evolved beyond the development of products focused
            solely on nutritional value toward foods that deliver tangible health benefits. Emerging concepts such as
            “Food as Medicine” and “Precision Nutrition” have reshaped consumer expectations, driving demand for
            products that not only provide essential nutrients but also contribute to disease prevention, healthy aging,
            and improved quality of life. This trend has become increasingly important in response to the rapid growth
            of aging populations and the global burden of non-communicable diseases (NCDs).



               Soybean has attracted considerable attention as a valuable   be classified into two major forms: aglycones (including
             source of plant-based protein and bioactive compounds.   daidzein, genistein, and glycitein) and glycosides (including
             Among these, isoflavones have been extensively studied for   daidzin, genistin, and glycitin). In raw soybeans, isoflavones
             their potential roles in promoting bone health, cardiovascular   predominantly occur as glycosides, in which sugar moieties
             function, and reducing the risk of certain chronic diseases,   are attached to the core structure. These compounds
             including hormone-related cancers.                   generally exhibit poor intestinal absorption due to their
               However, the health-promoting properties of soybean   relatively large molecular size and  hydrophilic nature.
             products are not solely determined by their original composition.   Before absorption can occur, glycosides must be hydrolyzed
             Processing technologies, particularly fermentation, play a   by β-glucosidase enzymes to release the corresponding
             crucial role in modifying the biochemical profile of soybeans   aglycone forms.
             and enhancing the production of bioactive metabolites with   Fermentation serves as an effective bioconversion process
             improved biological activities.                      that facilitates this transformation. During fermentation,
               This understanding has transformed traditional fermented   microorganisms produce β-glucosidase enzymes capable of
             soybean products such as tempeh, natto, miso, and Thua   converting glycoside isoflavones into aglycones. As a result,
             Nao from conventional ethnic foods into promising sources   fermented soybean products typically contain significantly
             of functional ingredients with broad applications in the   higher proportions of aglycone isoflavones than their non-
             development of next-generation health foods.         fermented counterparts.
                                                                     This conversion is particularly important because
             Fermentation and the Enhancement of Isoflavone       aglycones possess greater bioavailability. Their smaller
             Bioavailability                                      molecular size and increased lipophilicity enable  more
             Isoflavones are phenolic compounds naturally abundant   efficient absorption through the intestinal epithelium, allowing
             in soybeans. Based on their chemical structures, they can   them to exert biological functions more effectively within the
                                                                  human body.
            30   FOOD FOCUS THAILAND  JUL  2026


                                                                                                                     23/6/2569 BE   11:39
         28-31_Special Focus_����� IFRPD.indd   30                                                                   23/6/2569 BE   11:39
         28-31_Special Focus_����� IFRPD.indd   30
   25   26   27   28   29   30   31   32   33   34   35